Next Generation Migraine Therapies

ABOUT
The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers. Brought to you by the American Headache Society, the program covers diagnosis and treatment of migraine, and updates on the latest science.

In-Person Programs
The AHS is excited to announce in-person programming will resume July 16, 2022 at the Hilton Portland downtown hotel in Portland, OR. Click an upcoming program below to view the program agenda and register.

Education On Demand Program
Past NGMT content is available virtually via the AHS Education On Demand platform. The program will center around pre-recorded lectures on new acute migraine treatments and prevention, behavioral approaches in migraine, and migraine diagnosis, epidemiology, and pathophysiology. Registered in-person attendees will also have access to this additional content.

Live Q&A
NGMT registrants will also have access to register separately for live Q&A sessions with migraine experts for additional CME via the Education On Demand platform. Registrants are encouraged to attend an in-person program or view the On Demand content first, then register for an available Live Q&A that works for your schedule. Experts will cover various topics including the following frequently asked questions:

  • How do you select which patients are candidates for new therapies?
  • Can you safely combine CGRP therapies  with other drugs?
  • Can you combine a CGRP monoclonal antibody with Onabotulinum toxin A or with a CGRP receptor antagonist (gepant)?
  • Can you combine a gepant with a triptan or a ditan?
  • When do you recommend neuromodulation?
  • What behavioral treatments work the best for people with migraine?
  • Which of the newer treatment options would you consider to treat migraine during pregnancy or lactation?
  • What are some treatment options for people with migraine who are above 60?
  • Have these newer treatments been studied in children?
  • Do the newer treatments work for menstrual migraine?